Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Allergic Rhinitis Drugs Market

Allergic Rhinitis Drugs Market Size

  • Report ID: GMI5413
  • Published Date: Jan 2023
  • Report Format: PDF

Allergic Rhinitis Drugs Market Size

Allergic Rhinitis Drugs Market size was recorded at over USD 12 billion in 2022. Driven by consistent innovations in allergic rhinitis drugs, the industry is estimated to grow at more than 2.5% CAGR from 2023 to 2032.


The increasing prevalence of allergic rhinitis is expected to fuel market growth. Several epidemiological studies have shown that the disease burden caused by allergies has significantly increased in the past few years. Moreover, air quality deterioration in developed nations due to cumulative industrial practices has escalated the number of allergic rhinitis cases, which is speculated to bolster product penetration.


Allergic Rhinitis Drugs Market

To understand key trends  
Download Free Sample

Furthermore, technological advancements in the field of allergy diagnosis and treatment are also forecast to positively influence business dynamics. The considerable surge in deploying technologically advanced methods, tools, and mechanisms by authorities and organizations globally has uplifted product adoption.


Side effects associated with allergic rhinitis treatments are a major factor restraining market growth. The most frequent side effects of treating allergic rhinitis are nosebleeds, excruciating migraines, eye and nose discomfort, urinary flow in males, and boost blood pressure in hypertensive patients. Altogether, the growing practice of self-medication without a doctor's prescription leads to difficulties. Nonetheless, mounting healthcare spending and the availability of highly potent drugs are likely to aid market players in overcoming this issue.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for allergic rhinitis drugs was valued at more than USD 12 billion in 2022 and is set to progress at over 2.5% CAGR over the next 10 years owing to technological advancements in the field of allergy diagnosis and treatment.

Online channel segment is foreseen to reach over USD 4 billion by the end of 2032 on account of the availability of swift service, beneficial discounts & offers from various manufacturers, and the strong preference of elderly patients.

Oral segment is poised to garner more than USD 6.5 billion in revenue by 2032 as a result of its high level of convenience, low cost, and non-invasive approach.

Allergic rhinitis drugs market in North America accounted for more than 37% of the revenue share in 2022 due to soaring technological developments in treatment methods and rising healthcare expenditures in the region.

Allergic Rhinitis Drugs Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 18
  • Tables & Figures: 351
  • Countries covered: 18
  • Pages: 220
 Download Free Sample